The study and its comparison
A single-center blinded pilot enrolled forty adults with overweight or obesity and insulin resistance; thirty-two completed it. They received live or pasteurized Akkermansia muciniphila or placebo for three months. [1]
Pasteurized bacteria improved measured insulin sensitivity and reduced insulin and total cholesterol compared with placebo. The approximately 2.3-kilogram weight difference had a P value of 0.091, so it was not a confirmed weight-loss effect. [1]
What the finding establishes
Small groups and multiple measurements make this exploratory evidence. Tolerability during three months cannot establish safety for every population or commercial preparation. Authors disclosed related patent interests; complete funding was not established from the abstract. A living preparation and a pasteurized one should not be treated as identical. [1]
A hypothetical distinction
Imagine a metabolic test improves while the weight comparison remains uncertain. Do not turn the first finding into proven weight loss.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.